Physician profile
Nancy Bello
NPI 1669734620
$598.90
in general payments reported to CMS, 2019-2025
8 companies · $19.18 in 2025
The $19.18 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $202 · 2022: $138 · 2023: $127 · 2024: $113 · 2025: $19.18.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $259.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $258.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $260.43 | 2022-2024 | Botox, Ubrelvy |
| Alexion Pharmaceuticals, INC. | $167.69 | 2019 | |
| Glaxosmithkline, LLC. | $65.10 | 2023-2025 | Benlysta |
| Ipsen Biopharmaceuticals, INC | $34.12 | 2019 | |
| Argenx US, INC. | $22.00 | 2023 | Vyvgart |
| Mallinckrodt Hospital Products INC. | $18.23 | 2024 | Acthar |
| Actelion Pharmaceuticals US, INC. | $18.02 | 2024 | Opsumit |
| Boston Scientific Corporation | $13.31 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nancy Bello listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.